anonymous
Guest
anonymous
Guest
Based on the Phase 3 results, Keryx plans to submit a supplemental new drug application (sNDA) for approval to the U.S. FDA in the third quarter of 2016
So hectic in Boston that no one can even update a website.
So hectic in Boston that no one can even update a website.